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Abstract 
The potential impact of endocrine disrupting chemicals (EDCs) in the aquatic environment has 
driven the development of screening assays to evaluate the estrogenic properties of chemicals 
and their effects on aquatic organisms such as fish. However, obtaining full concentration-
response relationships in animal (in vivo) exposure studies are laborious, costly and unethical, 
hence a need for developing feasible alternative (non-animal) methods. Use of in vitro bioassays 
such as primary fish hepatocytes, which retain many of the native properties of the liver, has 
been proposed for in vitro screening of estrogen receptor (ER) agonists and antagonists. The 
aim of present study was to characterize the molecular Mode of Action (MoA) of the ER agonist 
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17α-ethinylestradiol (EE2) in primary rainbow trout (Oncorhynchus mykiss) hepatocytes. A 
custom designed salmonid 60,000-feature (60k) oligonucleotide microarray was used to 
characterize the potential MoAs after 48h exposure to EE2. The microarray analysis revealed 
several concentration-dependent gene expression alterations including classical estrogen 
sensitive biomarker gene expression (e.g. estrogen receptor α, vitellogenin, zona radiata). Gene 
ontology (GO) analysis displayed transcriptional changes suggesting interference of cellular 
growth, fatty acid and lipid metabolism potentially mediated through the estrogen receptor 
(ER), which were proposed to be associated with modulation of genes involved in endocrine 
function and reproduction. Pathway analysis supported the identified GOs and revealed 
modulation of additional genes associated with apoptosis and cholesterol biosynthesis. 
Differentially expressed genes (DEGs) related to impaired lipid metabolism (e.g. peroxisome 
proliferator-activated receptor α and γ), growth (e.g. insulin growth factor protein 1), phase I 
and II biotransformation (e.g. cytochrome P450 1A, sulfotransferase, UDP-
glucuronosyltransferase and glutathione S-transferase) provided additional insight into the 
MoA of EE2 in primary fish hepatocytes. Results from the present study suggest that 
biotransformation, estrogen receptor-mediated responses, lipid homeostasis, growth and 
cancer/apoptosis in primary fish hepatocytes may be altered after short-term exposure to ER-
agonists such as EE2. In many cases the observed changes were similar to those reported for 
estrogen-exposed fish in vivo. In conclusion, global transcriptional analysis demonstrated that 
EE2 affected a number of toxicologically relevant pathways associated with an estrogenic MoA 
in the rainbow trout hepatocytes.  
Key words: Oncorhynchus mykiss, primary hepatocytes, EDCs, microarray, gene expression, 
estrogen receptor 
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1 Background  
Compounds that modulate the endocrine system and cause adverse effects causally related to 
these changes are known as endocrine disrupting chemicals (EDCs). These chemicals may enter 
the environment through anthropogenic activities such as effluents of sewage treatment plants, 
industrial processes and agricultural run-off (Sumpter, 2005). During the past decade, 
increasing awareness of the adverse effects of EDCs in wildlife and human has given rise to the 
implementation of stricter legislations in international regulatory organizations worldwide 
(Hecker and Hollert, 2011). Adverse effects such as impaired reproduction in fish, reproductive 
disorders and various cancer types (e.g. breast and ovary cancer) in human and other mammals 
have been associated with EDCs such as 17α-ethinylestradiol (EE2), dichlorodiphenyl-
trichloroethane (DDT) and bisphenol A (BPA) (Benninghoff and Williams, 2008; Purdom et 
al., 1994; Soto and Sonnenschein, 2010; vom Saal et al., 2007). Characterization of a chemical’s 
mode of action (MoA) involving interference with specific molecular, cellular and biochemical 
changes, behavioral alterations and adverse effects are often laborious and expensive due to 
extensive use of animals (Aardema and MacGregor, 2002). Although the use of single 
biomarker screening approaches has facilitated the understanding of MoAs of EDCs, the 
knowledge obtained from such biomarker studies is still limited, as the response of a single 
endpoint may not always represent complex biological responses at higher levels of 
organization.  
In recent years, the development of broad-content screening approaches such as transcriptomics 
has made it possible to characterize the global gene expression changes after exposure to single 
EDCs and mixture of these in different in vitro and in vivo experimental models (Finne et al., 
2007; McHale et al., 2010; Wang et al., 2010; Yang et al., 2007). Deciphering complex 
molecular interactions of chemicals using transcriptomic studies has enabled detailed studies 
on the in vivo responses of (xeno)estrogens in common laboratory  species such as zebrafish 
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(Danio rerio), fatheaded minnow (Pimephales promelas), rainbow trout (Oncorhynchus 
mykiss), but also non-model species such as coho salmon (Oncorhynchus kisutch) (Harding et 
al., 2013; Hook et al., 2008; Levi et al., 2009; Villeneuve et al., 2011; Wang et al., 2010). Many 
of these studies involve the analysis of estrogenic responses, which typically involve the 
binding and activation of the estrogen receptor (ER) and of genes containing estrogen response 
elements (ERE) to initiate multi-organ endocrine responses in fish. The ER signaling pathway 
may further regulate the expression of several classical estrogenic biomarker genes such as the 
egg-yolk precursor protein vitellogenin (vtg), egg envelope proteins zona pellucida and zona 
radiata protein (zrp) (Arukwe et al., 1997; Sumpter and Jobling, 1995). The endocrine 
modulatory effects of EDCs have been extensively studied in vivo, including the 
characterization of MoA associated with hormone binding, lipid and cholesterol metabolism 
and steroidogenesis, immune function and ion homeostasis in fish (Colli-Dula et al., 2014; 
Flores-Valverde et al., 2010; Hook et al., 2007; Kausch et al., 2008; Levi et al., 2009; Wit et 
al., 2010). Various estrogen-mediated responses have also been observed in biomarker studies 
in various piscine in vitro (non-animal) bioassays, and consequently led to the proposal of using 
these experimental models as screening assays for environmental estrogens and antiestrogens 
(Björkblom et al., 2008; Hultman et al., 2015; Kordes et al., 2002; Navas and Segner, 2006; 
Rankouhi et al., 2004; Tollefsen et al., 2003). 
Use of alternative approaches provided by in vitro methods have offered rapid screening 
methods and facilitated better understanding of the MoA of chemicals whilst implementing the 
3R`s (refinement, reduction and replacement) into toxicological testing (National research 
council (NRC), 2007). In vitro hepatic models such as primary hepatocytes have demonstrated 
to be advantageous proxies for the assessment of in vivo bioactivity as the cells retain many of 
the native hepatic functions including biotransformation, detoxification and ER-mediated 
responses (Flouriot et al., 1993; Pedersen and Hill, 2000; Pesonen and Andersson, 1997; Segner 
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and Cravedi, 2000). The hepatocytes have previously demonstrated their potential for 
toxicological screening of cellular toxicity, endocrine disruption (ED) and bioaccumulation in 
various assay formats including suspension, monolayer and 3-dimensional spheroid cultures 
(Baron et al., 2012; Hultman et al., 2015; Mingoia et al., 2010; Smeets et al., 1999; Tollefsen 
et al., 2008a). Despite the broad applicability of such assays, thorough characterization of the 
MoAs and concentration-dependent global changes of gene and protein expression are 
generally lacking, and effort to provide this for EDCs is highly warranted.  
The objectives of this study were 1) to characterize the molecular MoAs of the ER agonist -
17α-Ethinylestradiol (EE2) in primary rainbow trout (Oncorhynchus mykiss) hepatocytes after 
a short-term (48h) in vitro exposure; 2) to determine the concentration-dependent 
transcriptional changes occurring, and 3) to evaluate the potential of primary hepatocytes to 
predict in vivo hepatic responses in fish.   
 
2 Material and methods  
2.1 Chemicals 
17α-Ethinylestradiol (EE2, ≥98%, CAS 57-63-6) and sodium bicarbonate (CAS 144-55-8) were 
purchased from Sigma–Aldrich (St. Louis, MI, US). The test chemical was dissolved in 
dimethylsulfoxide (DMSO) and stored in the dark at -20oC until use.  
2.2 Fish 
Sexually immature rainbow trout (200-500g) from the same fish stock were obtained from the 
Valdres rakfisk AB hatchery (Valdres, Norway) and reared at the Department of Biology, 
University of Oslo (Norway) for a minimum of 4 weeks prior to the start of the studies. The 
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fish were maintained in tap water at 6±2 oC, pH 6.6, 100% air saturation and light regime of 
12h light/12h dark. Rainbow trout were fed daily with commercial pellets (Skretting, Stavanger, 
Norway) corresponding to approximately 0.5% of total body weight. 
2.3 Cell culture and exposure  
A total of four donor fish were collected (January-July, 2012) and terminated by cephalic 
concussion, followed by immediate dissection to expose the abdominal cavity. Only juvenile 
fish (with no visual gonads) were used in a 2-step hepatic cell isolation procedure as described 
by Tollefsen et al. (2003) and modified for studies on gene expression by Hultman et al. (2015). 
The viability of primary hepatocytes (>80%) was assessed using a Bürker counting chamber 
and trypan blue:cell suspension (2:1). The cell suspension was diluted to 500 000 cells/ml in 
serum-free L-15 medium with phenol-red containing amphotericin (0.25 g/ml), L-glutamine 
(0.29 mg/ml), streptomycin (100 g/l), penicillin (100 Units/ml) and NaHCO3 (4.5 mM), seeded 
in 24- well PrimariaTM microtiter plates (Falcon, Becton Dickinson Labware, Oxnard, CA, USA 
) with a density of 625 000 cells/well and incubated in ambient atmosphere at 15oC. After 24 
hours of acclimation to the test wells, 50% of the medium was removed from the cells and 
replaced with media spiked with EE2 (0.03, 0.3, 3 and 30 nmol/L (nM)) or solvent control 
(0.1% DMSO) in triplicate. The chemical exposure concentration in the medium at the start of 
the experiment was verified by ultra-performance liquid-chromatography tandem mass 
spectrometer (UPLC-MS) analysis on derivatized EE2 and d3 labeled estradiol (d2-E2) and 
described in detail by Hultman et al. (2015). The measured concentrations ranged between 75% 
and 93% of the nominal concentrations (Hultman et al., 2015). After 48h exposure, the test 
medium was removed and the cells were sampled and lysed with RNeasy lysis buffer (Qiagen 
GmbH, Hilden, Germany) and stored at -80oC for later RNA isolation and gene expression 
analysis.  
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2.4 Gene expression analysis 
2.4.1 Microarray analysis  
A high-density (60,000-feature) custom salmonid oligonucleotide microarray (Agilent 
Technologies, City, Country; GEO accession number: GPL18864) was used to study the global 
transcriptional changes in the rainbow trout hepatocytes. The performance of the array was 
thoroughly evaluated for different salmonid species and pollutants (Song et al., 2012). Prior to 
microarray hybridization, the frozen primary hepatocytes were subjected to RNA extraction 
using Qiagen RNeasy Plus mini kit with on-column DNAs treatment (Qiagen GmbH, Hilden, 
Germany) according to the manufacturer’s instructions with minor modifications to 
accommodate high RNA purity and yield. The modifications included extended incubation time 
of RNA membrane-bound washing buffer (2-3 minutes) and increased centrifugation time and 
speed (35 sec, 9700 g), with a final removal of excess fluid from the O-ring prior to RNA 
elution. Protocol modifications were performed in order to remove excess guanine salts and 
avoid the need for further clean-up/purification of the samples. The RNA concentration was 
measured spectrophotometrically (Spectrophotometer ND 1000, Nanodrop technologies Inc., 
Wilmington, USA) with quality cut-off criteria as follows: 280/260 ratios of >2.0 and 260/230 
ratios of >1.8. The RNA integrity was assessed using Agilent Bioanalyzer RNA 6000 nano 
series kit (Agilent technologies, Santa Clara, CA, USA), with samples obtaining RIN value 
>8.0 passing the quality cut-off criteria (Fleige and Pfaffl, 2006). Technical replicates of RNA 
were pooled and the four biological replicates (individual batches of cells from different fish) 
were used in the subsequent analysis. The biological replicates were subsequently subjected to 
cDNA synthesis (input: 50 ng total RNA), linear amplification, cRNA synthesis and Cyanine-
3 (Cy-3) labelling strictly performed according to Agilent's “One-color Microarray-Based Gene 
Expression Analysis (Low Input Quick Amp Labeling) protocol, Version 6.5 May 2010”. The 
Cy-3 labelled samples were hybridized on the microarray, followed by washing and scanning 
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in a high resolution microarray scanner (Agilent technologies, USA) at 3 μm resolution and 
scanning area of 61×21.6mm.   
2.4.2 Quantitative Real time PCR (qPCR) 
Verification of differentially expressed genes (Table 1) was performed by quantitative real-time 
polymerase chain reaction (qPCR) essentially as described by Hultman et al. (2015). Synthesis 
of cDNA was performed by reverse transcription of total RNA (0.5-1μg) using Quanta 
qScript™ cDNA Synthesis Kit (Quanta Biosences Inc., Gaithersburg, USA) according to the 
manufacturer’s instructions. The primer optimization was performed with a CFX-384 thermal 
cycler (Bio-Rad laboratories Inc., USA) using a 5-step dilution series (2.5-50 ng/reaction) with 
pooled template cDNA. SYBR®Green Supermix (Quanta Biosences Inc., Gaithersburg, USA) 
was used in the qPCR amplification reaction, where technical triplicates of 10 ng 
template/reaction were used in the final mastermix reaction (20 μl/reaction). The primers were 
obtained from previously published papers (Table 1) and were purchased from Eurofins MWG 
synthesis GmbH (Ebersberg, Germany). Primers were optimized for concentrations and 
annealing temperature in order to yield an amplification efficiency of 90-110%. The qPCR 
protocol was performed as following, Cycle 1: 95oC for 3 min, Cycle 2-40: 95oC for 20 sec, 
followed by the specific primer annealing temperature for 20 sec and 72oC for 20 sec. All 
primers run had a none-template control (NTC) and a no-reverse transcriptase control (NRT) to 
exclude any contamination of primer or presence of genomic DNA in the mastermix or the RNA 
sample that may influence the qPCR analysis. The qPCR analysis reported no amplification of 
either NRT or NTC for any of the primers used.   In the end of the qPCR protocol a melt curve 
analysis was performed, verifying that no primer-dimer formation or unspecifically amplified 
products were formed in the samples. Accepted threshold cycle (Cq)-value of NTC was set to 
be either non-detectable (N/A) or Cq value >30 with minimum 7 cycles in between template 
replicate and NTC. The expression of elongation factor 1α (EF1α) was relatively stable in all 
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treatments and was therefore used as a reference gene (Table 1). Data normalization was 
performed using the Pfaffl method (Pfaffl, 2001).  
2.5 Statistics and bioinformatics 
2.5.1 Microarray 
Scanned microarray images were quality assessed and extracted using Agilent Feature 
Extraction software v10.7 (Agilent Technologies). The raw data were subjected to 
normalization, including correction for background signal, flagged for missing and low quality 
features, followed by statistical analysis using GeneSpring GX v12.6 (Agilent Technologies). 
Determination of differentially expressed genes (DEGs) was performed using one-way analysis 
of variance (ANOVA), followed by Tukey`s post hoc test (p<0.05). Statistics were not corrected 
for Benjamin and Hochberg (BH) false discovery rate (FDR) correction to avoid potential loss 
of biologically relevant data (Villeneuve et al., 2011). The Venn diagrams were generated using 
Venny (Oliveros, 2007) and the Gene ontology (GO) enrichment analysis was performed in 
Cytoscape v2.8 (Smoot et al., 2011) using the application Bingo v.2.4 (Maere et al., 2005). 
Pathway and protein-protein interaction network analyses were performed using Ingenuity 
Pathway Analysis (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity) on basis of 
identification of mammalian orthologs by the standalone Inparanoid 4.1 algorithm (Ostlund et 
al., 2010) implementing BLAST 2.2.27+ binaries from the NCBI expert-curated mammalian-
based databases Ensembl, Entrez Gene, RefSeq, GenBank, UniProt/Swiss-Prot Accession, 
GenPrept and UniGene.   
2.5.2 qrtPCR analysis 
Prior to statistical analyses, the qPCR data was normalized against a reference gene followed 
by the Grubb's outlier test (Burns et al., 2005) to exclude clearly erroneous values (10 out of 
140 values removed). The statistical analyses were performed in Graphpad Prism v5.04 
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(Graphpad Software, Inc., San Diego, CA, USA), applying a one-way ANOVA test, followed 
by Tukey`s post hoc test. The significant level was set to p<0.05 for all statistical tests.     
 
3 Results  
The qPCR analysis reported no amplification of either NRT or NTC for any of the primers used. 
3.1 Global transcriptional changes 
A total of 1098 differentially expressed gene (DEG) transcripts (707 up-regulated and 391 
down-regulated) were identified to be regulated in the EE2 exposed cells when compared to the 
control. Concentration-dependent transcriptional changes were further determined using Tukey 
HSD post hoc test. A total of 66 (up-regulated: 27, down-regulated: 39), 114 (up-regulated: 84, 
down-regulated: 30), 468 (up-regulated: 301, down-regulated: 167) and 992 (up-regulated: 695, 
down-regulated: 297) genes were identified to be differentially expressed after exposure to 0.03, 
0.3, 3 and 30 nM EE2, respectively (Fig. 1). The Venn diagram analysis identified 3 up-
regulated DEGs being commonly regulated across all treatments (i.e. transposable element Tc1 
transposase (tca1), diaphanous homolog 2 (diap2) and uncharacterized protein) and 2 down-
regulated (i.e. dedicator of cytokinesis protein 9 (dok9) and protein naked cuticle homolog 2-B 
(nkd2b)). The cells exposed to 3 and 30 nM EE2 had a high number of common DEGs being 
regulated (246 DEGs, 179 up- and 67 down-regulated). Both total number (Fig. 1) and the 
expression of the DEGs were found to be concentration-dependent and the complete list of 
DEGs can be found in supplementary table A.     
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3.2 Gene Ontology-based functional enrichment analysis 
The biological roles of the DEGs were first characterized by functional Gene Ontology (GO) 
analysis and grouped into molecular functions, biological processes and cellular components 
(Table 2). Assigning the biological roles for the gene products naturally supposes that they are 
the same in rainbow trout hepatocytes as in mammals, which the GO is based on. The total 
numbers of overrepresented GO biological processes and molecular functions were found to be 
affected in a concentration-dependent manner between 0.3-30 nM EE2. Increased enrichment 
of DEGs related to functional categories such as lipid and fatty acid metabolism was observed 
between 0.3-3 nM EE2, whereas biological processes related to reproduction and the regulation 
of the endocrine system were mainly observed between 3-30 nM EE2. A complete list of GO 
terms associated with the DEGs can be found in supplementary table B.  
3.3 Ortholog-based functional enrichment analysis 
The DEGs were further mapped to their mammalian orthologs to better understand their 
biological roles using well-curated mammalian databases, assuming that the functions of the 
gene products are conserved between mammals and fish. A total of 54.3% (0.03 nM), 52% (0.3 
nM), 57.4% (3 nM) and 58.5% (30 nM) of the rainbow trout DEGs were successfully mapped 
to mammalian orthologs (see suppl. table B for a complete list of mapped orthologs). The gene 
network, toxicity and canonical pathway analysis revealed a concentration-dependent increase 
of enriched gene/protein networks and pathways. 
3.3.1 Gene networks 
The list of successfully mapped orthologs was subjected to protein-protein interaction (PPI)-
based gene network analysis to obtain a better overview of the functional processes associated 
with the DEGs identified (Table 3.). The gene networks of 0.03 nM EE2 were mainly related 
to cell signaling, molecular transport and nucleic acid metabolism, whereas 0.3 nM EE2 
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regulated DEGs associated with cellular function and maintenance, small molecule 
biochemistry and cellular development. The 3 nM and 30 nM EE2 exposure predominantly 
resulted in transcriptional changes associated with hematological disease, hereditary disorder, 
carbohydrate metabolism and post-translational modification, lipid metabolism and alterations 
of small molecule biochemistry in the cells, respectively.  
3.3.2 Toxicity pathways 
The toxicity pathway analysis was performed to better understand the potential MoAs of EE2 
based on the mapping of DEGs to well-characterized mammalian toxicity pathways. No toxicity 
pathways were identified to be commonly affected across all EE2 concentrations (Fig. 2). 
Exposure to 0.03 nM EE2 predominantly altered the expression of DEGs associated with 
toxicity pathways related to organismal injury and abnormalities. One toxicity pathway 
(negative acute phase response proteins) was found to be affected by 0.3 nM EE2, whereas 3 
nM EE2 led to alterations of a number of DEGs associated with lipid metabolism, endocrine 
system development and function, as well as cellular growth and proliferation. A majority of 
the identified DEGs in the 30 nM EE2-exposed hepatocytes were related to processes such as 
cell death and survival, cardiovascular disease, cellular growth and proliferation. The complete 
list of toxicity pathways is provided in supplementary table C.    
3.3.3 Canonical pathways 
Canonical pathway analysis was performed to obtain more detailed knowledge on the potential 
MoAs of EE2. The number of toxicologically relevant canonical pathways increased in an 
apparent concentration-dependent manner (Table 4). A total of 10, 5, 28 and 36 pathways were 
uniquely affected by 0.03, 0.3, 3 and 30 nM EE2, respectively.  Two canonical pathways (CCR3 
Signaling in Eosinophils and Protein Kinase A Signaling) were commonly affected at all EE2 
concentrations (Supplementary table D). The cells exposed to 3 nM and 30 nM EE2 responded 
by modulating DEGs involved in cell growth and development, immune response, intracellular 
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and second messenger signaling, apoptosis and metabolic pathways. Exposure to 0.03 nM EE2 
led to the enrichment of DEGs in pathways linked to intracellular and second messenger 
signaling (e.g. glucocorticoid receptor- and insulin receptor signaling), whereas DEGs 
regulated by 0.3 nM EE2 were enriched in the apoptotic signaling pathway.  In the cells exposed 
to 3 nM EE2,  gene transcripts related to cell growth and development (e.g. Growth hormone 
(GH) and Insulin growth factor-1 (IGF-1) signaling), apoptosis (e.g. death receptor signaling), 
intracellular and second messenger signaling (e.g. Glucocorticoid receptor and Calcium 
signaling) and nuclear receptor signaling (e.g. Pregnane X receptor/Retinoic X receptor 
(PXR/RXR) activation) were mainly affected. Primary hepatocytes exposed to the highest (30 
nM) concentration of EE2 exhibited enrichment of DEGs associated with regulation of cell 
growth and development (e.g. Corticotropin-Releasing Hormone Signaling), neurotransmitters 
and other signaling pathways (e.g. Gonadotropin-releasing hormone (GNRH) signaling), 
nuclear receptor signaling (e.g. Peroxisome proliferator-activated receptor (PPAR) signaling)) 
and disease-specific pathways (e.g. molecular mechanism of cancer). A detailed list of the 
canonical pathways can be found in supplementary table D. 
3.4 Quantitative real-time polymerase chain reaction verification 
Verification of the microarray results was performed on a selection of DEGs involved in key 
biological processes such as ER regulation (esr1, vtg1), biotransformation (cytochrome P450 
1A (cyp1a)), lipid metabolism/homeostasis (pparγ) and cellular growth (growth hormone 
receptor 1 (ghr-1), IGF binding factor 1 (igfbp-1)). The selected genes were consistently 
expressed in a concentration-dependent manner in coherence with the microarray data, although 
some differences in the magnitude of expression were observed. In addition, pparα was verified 
as regulated using qPCR, despite not being identified as significantly altered on the microarray. 
Among the genes analyzed, four (esr1, vtg1, igfbp-1 and pparα) were verified to be significantly 
regulated when compared to the solvent control (Fig. 3 and 4). An apparent concentration-
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dependent regulation was also observed in the remaining genes, and found to be in general 
agreement with the microarray data.  
4 Discussion 
Exposure to ER-agonists such as EE2 has been reported to affect a number of estrogen sensitive 
genes and their proteins product in both in vivo and in vitro fish models (Arukwe et al., 1997; 
Finne et al., 2007; Hultman et al., 2015; Sumpter and Jobling, 1995). The majority of  available  
studies with EDCs have been focused on a few responses associated with the endocrine 
functions in fish, thus contributing to the development and evaluation of a number of estrogen 
sensitive biomarkers suitable for laboratory and field-based studies (Arukwe et al., 1997; 
Folmar et al., 2000; Harries et al., 1997; Purdom et al., 1994; Sumpter and Jobling, 1995). 
Although this approach has been highly successful, most of these studies have limited their 
approaches to the MoA characterization using single or small suites of biomarkers, which only 
provide a snapshot of the biological responses to EDCs. The present study has implemented a 
broad-content transcriptomic (microarray) analysis to provide an unbiased characterization of 
the complex and concentration-dependent cellular transcriptional responses in rainbow trout 
hepatocytes after exposure to the ER-agonist EE2. The exposure duration (48h), and bioassay 
protocol have previously been identified as optimal for determination of Vtg gene and protein 
expression in rainbow trout hepatocytes exposed to non-cytotoxic concentrations of EE2 
(Hultman et al., 2015). Dimethylsulfoxide (0.1%) was used as the solvent control in these 
studies as it has been shown to not affect Vtg gene and protein expression (Hultman et al., 
2015).  
 
The present study identified clear concentration–dependent responses in DEGs (Fig. 1,3 and 4), 
GOs (Table 2) and pathways (Fig. 2; Table 3) relevant for a number of potential toxic MoAs 
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(Fig. 5 and 6A-D). The lowest concentration  of EE2 (0.03 nM) affected a limited number of 
DEGs (66) mainly associated with cellular signaling, cellular transport,  and biotransformation, 
whereas 0.3 nM EE2 modulated about twice as many DEGs (114) that were related to cellular 
metabolism of fatty acids and lipids, cellular development, and apoptosis. Ten times higher 
concentrations of EE2 (3 nM) led to regulation of 466 DEGs predominantly associated with 
cellular processes such as growth, development, metabolism, apoptosis, but also to nuclear 
receptor signaling, endocrine regulation, reproductive functions, immune functions and cancer 
development. The highest concentration of EE2 (30nM) affected a high number of DEGs (992), 
whereof many were associated with similar functions as those observed for 3 nM, but 
modulation of DEGs associated with cell cycle regulation neuro-signaling were also observed. 
Overall, the lowest concentration of EE2 (0.03 nM) was considered to only marginally affect 
toxicologically-relevant processes, whereas a number of processes relevant for endocrine 
disruption in fish was identified at higher EE2 concentrations (Fig. 2) and discussed in detail 
below. 
 
4.1 Estrogen receptor signaling 
Estrogens bind to and activate the ER and ER-mediated signaling pathways, which may regulate 
sexual development and reproduction in fish. The genomic ER signaling pathway is well 
characterized and includes homodimerization of the ligand and ER heat shock protein complex, 
translocation of the dimer into the nucleus, and recruitment of co-regulators to the ERE-
promoter region leading to induced or suppressed transcription of downstream genes (Fig. 3 
and 5). Exposure of the primary rainbow trout hepatocytes to EE2 in the present study resulted 
in a concentration-dependent up-regulation of genes encoding ERα (esr1), transcriptional 
regulators (e.g. nuclear receptor coactivator 4 (ncoa4), nuclear receptor subfamily group 
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member 1 (nr2f1), nuclear receptor subfamily group member 2 (nr0b2)), and genes encoding 
downstream reproductive-relevant hepatic proteins such a vitellogenin (vtg1) and zona radiata 
proteins (zrp3 and zrp4) (Fig. 3 and 6 B-D) whereof several have previously been reported to 
respond to estrogens (Colli-Dula et al., 2014; Doyle et al., 2013; Hoffmann et al., 2006; 
Mortensen and Arukwe, 2007). Many of these genes (i.e. esr1, vtg and zrp) have been proposed 
as biomarkers for estrogenicity in fish (Arukwe et al., 1997; Heppell et al., 1995; MacKay et 
al., 1996; Sumpter and Jobling, 1995), and the present microarray and qPCR analysis (Suppl. 
Table A, fig. 3) confirmed that they were highly responsive to estrogens at low concentrations 
in vitro (NOEC of 0.03-0.3 nM EE2). Other estrogen responsive genes such as follistatin (fst), 
fatty acid binding protein 3 (fabp3) and nitric oxide synthase interacting protein (nosip) were 
also regulated in the primary hepatocytes. Although the roles of these genes were not studied 
in detail herein, they have previously been reported to be regulated in the liver of fish after 
exposure to E2 and EE2 (Gunnarsson et al., 2007; Levi et al., 2009).  
 Interestingly, the microarray analysis revealed that nr0b2 (also known as the small heterodimer 
partner, SHP), the product of which is a potential transcriptional repressor of esr1 and 
downstream genes (Ehrlund and Treuter, 2012), was significantly up-regulated after exposure 
to 30 nM EE2. Although controversy still exists with regard to the actual role of nr0b2 in fish 
(Park et al., 2007), up-regulation of nr0b2 may provide a potential explanation for the slight 
reduction in transcriptional activation observed for esr1 and vtg1 after exposure to the highest 
EE2 concentration (Fig. 3). Although the repression of the vtg gene and protein expression at 
high estrogen concentrations have been amply demonstrated elsewhere (Hultman et al., 2015; 
Petersen and Tollefsen, 2011; Rankouhi et al., 2004), further investigations will be required to 
properly elucidate the role of nr0b2 in piscine ER signaling.  
Enrichment of hepatic DEGs in additional estrogen and ER-mediated pathways were identified 
to be associated with several reproductive processes involving calcium (e.g. oocyte formation), 
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GNRH (e.g. hormone regulation) and androgen signaling (Table 4) that is relevant also for other 
organs. These observations agree well with responses to estrogens in fish tissues such as the 
pituary (Harding et al., 2013). The GO-based functional analysis further identified calcium 
signaling being affected which is involved in various key regulatory processes in the cell such 
as cell death (Pretorius and Bornman, 2005), molecular transport, reproduction, GNRH 
signaling and hormone signaling (Harding et al., 2013; Jobin and Chang, 1992).  
 
 
4.2 Biotransformation  
Biotransformation  is a key step in the detoxification in organisms and important for the 
reduction of intracellular concentrations of both xenobiotics and compounds of endogenous 
origin (Newman, 2009). Several genes involved in the biotransformation of (xeno)estrogens 
were affected in the hepatocytes at low (0.03 nM), intermediate (0.3 and 3 nM) and high (30 
nM) concentrations of EE2. The present study identified differential modulation of genes 
involved in phase I (cyp1a and comt), phase II biotransformation (gst, sult6b1, ugt1b5, and 
ugt2a1) and phase III-multidrug transport (resistance) (abc and abcb11b). The induction of 
ugt2a1 (Suppl. table A) was consistent with increased hepatic glucurononyl conjugation of 
hydroxylated substrates from phase I biotransformation as previously described for endogenous 
steroids and xenobiotic compounds in fish (Gao et al., 2014). Subsequent induction of the bile 
salt pump abc and abcb11b, which are involved in hepatic cellular efflux transport of 
xenobiotics (Luckenbach et al., 2014) and reported to be induced by EE2 (Finne et al., 2007), 
confirm that EE2 was also actively excreted from the hepatocytes. Down-regulation of other 
phase II biotransformation genes such as gst, sult6b1, and ugt1b5, suggest that these pathways 
play less important roles in the biotransformation of estrogens in fish (Kurogi et al., 2013; 
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Mortensen and Arukwe, 2007; Skillman et al., 2006; Solé et al., 2000; Sovadinová et al., 2014; 
Wang et al., 2014).   
Interestingly, the cyp1a gene, which is normally induced by exposure to xenobiotics in fish 
(Schlenk et al., 2008), was suppressed in a concentration-dependent manner in both the 
microarray and qPCR analysis (Fig. 3). Down-regulation of cyp1a has previously been 
associated with estrogen exposure and  proposed to be the result of a uni- or bi-directional 
negative crosstalk between the upstream nuclear receptors ER and aryl hydrocarbon receptor 
(AhR) (Bemanian et al., 2004; Gräns et al., 2010). The present microarray study shows 
indication of such cross-talk as up-regulation of the ERα-recruited squelching nuclear factor 1 
(nf1b) may reduce AhR mediated cyp1a expression (Ricci et al., 1999). However the ahr gene 
transcript, assumed to be central in the AhR-ER cross-talk (Bemanian et al., 2004; Matthews et 
al., 2005; Ohtake et al., 2003; Safe and Wormke, 2003) was not significantly expressed. 
Although this lack of positive verification may have been due to high inter-replicate variation, 
additional studies to decipher the role of AhR in modulating the ER activity in fish may be 
warranted. This seems also to be the case for the CYP P450 isoform 2M1 (CYP2M1), a major 
regulator of lauric acid hydroxylation, which has been reported to be suppressed by estrogenic 
compounds (Sovadinová et al., 2014). However, this gene was not identified to be differentially 
regulated in the present study. Nevertheless, the present results clearly demonstrated that 
primary hepatocytes retain many of their native detoxification properties and agree with 
previous suggestions elsewhere (Finne et al., 2007; Hultman et al., 2015; Segner, 1998; Segner 
and Cravedi, 2000).   
4.3  Lipid and cholesterol homeostasis 
Disruption of steroidogenesis and lipid metabolism in fish exposed to estrogens may lead to 
accumulation of lipids, impairment of hormone, glucose and cholesterol homeostasis in various 
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organs (Koren et al., 1982; Tocher, 2003), affecting vitellogenesis and normal oocyte formation 
and development (Doyle et al., 2013; Levi et al., 2009; Luckenbach et al., 2008). Steroid, lipid 
(e.g. apolipoprotein and high density lipoprotein (HDL) cholesterol) and fatty acid homeostasis 
(metabolism, biosynthesis, uptake, and transport) is mainly regulated in the liver by pparα (Lee 
et al., 2003; Tocher, 2003), which in the present study was transcriptionally suppressed by EE2 
in a concentration-dependent manner (Fig. 4). Estrogens such as E2 and EE2 are not PPAR-
ligands themselves, but may indirectly interact with PPARs through crosstalk with the ER 
(Keller et al., 1995). This receptor crosstalk has been proposed to be involved in competitive 
binding of shared transcriptional co-regulators upon estrogen exposure (Wang and Kilgore, 
2002) in addition to incomplete PPAR binding to the ERE resulting in reduced transcriptional 
activation of PPAR (Keller et al., 1995), as indicated in the present work. Another abundantly 
expressed PPAR in the fish liver is the pparγ, the product of which is responsible for 
peroxisomal β-oxidation of fatty acids in fish (Ruyter et al., 1997), and may therefore aid the 
uptake and to some extent also metabolism of lipids in the liver. The present study identified 
that pparγ was significantly suppressed only at the highest EE2 concentration (30 nM) (Fig. 3), 
hence suggesting that pparγ is less susceptible to EE2-induced modulation than pparα in the 
hepatocytes. Nevertheless, suppression of pparα and pparγ in primary hepatocytes exposed to 
estrogens is suggestive of chemical interference with key regulators of lipid metabolism in fish 
hepatocytes.  
Impaired pparα expression may also affect transcriptional activation of apolipoprotein A-I 
(apoa1) and A-II (apoa2) in fish (Tocher, 2003), transcripts which the present study did not 
identify as significantly altered. These apolipoproteins have a major role in the uptake and 
transport of lipids across the cellular membrane and into the blood, where they function as co-
regulators in transport, lipoprotein uptake, lipid metabolism or act as inhibitors of catabolic 
pathways (Erkelens, 1989; Kingsbury and Bondy, 2003). In fish, apolipoproteins consist of 
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various classes including apolipoprotein a (apoa) and apolipoprotein e (apoe) which regulates 
the incorporation of lipids and lipoproteins in the oocyte (Luckenbach et al., 2008). Suppression 
of apo1a and apoe in liver tissue has previously been associated with exposure to E2 and EE2 
(Hoffmann et al., 2006; Martyniuk et al., 2007; Wit et al., 2010), which ultimately may modify 
uptake and transport of cholesterol and lipids during vitellogenesis and oocyte formation 
(Doyle et al., 2013; Hoffmann et al., 2006). None of these genes were identified as significantly 
regulated in the microarray analysis in the present study, an observation in line with previous 
transcriptional studies in primary hepatocytes (Finne et al., 2007; Sovadinová et al., 2014) and 
whole fish (Doyle et al., 2013; Levi et al., 2009) exposed to EE2 and E2. The lack of modulation 
of apo1 and apoe may suggest that lipid transport and uptake is maintained during 
vitellogenesis, hence allowing normal oocyte development (Doyle et al., 2013), which has 
previously been demonstrated to be compromised in fish after EE2 exposure (Schäfers et al., 
2007).  
Interestingly, genes associated with increasing biosynthesis and cellular uptake of cholesterol 
such as apof  (also known as lipid transfer inhibitor protein (ltip)), angiopoietin-related protein 
3, 7-dehydrocholesterol reductase (dhcr), low-density lipoprotein receptor (ldlr) and neutral 
cholesterol ester hydrolase 1 (nceh1) were all up-regulated in the EE2-exposed hepatocytes. 
These genes are associated  with increased cholesterol biosynthesis and transport during 
vitellogenesis in fish (Hoffmann et al., 2006; Kersten, 2005; Levi et al., 2009) and may be 
modified through ERα-mediated interference by negative feedback regulation of cholesterol 
biosynthesis (Wang et al., 2006).  
Overall, present study found xenoestrogen-mediated molecular changes associated with lipid 
and cholesterol homeostasis which previously has been proposed to affect fish through  
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disruption of sex steroid biosynthesis (Levi et al., 2009) and potentially cause delayed sexual 
maturation and subsequent reproductive success in fish (Schäfers et al., 2007). 
 
4.4 Cellular growth and development 
Impaired cellular growth and development in juvenile and adult fish has previously been 
associated with exposure to low concentrations of estrogenic compounds (Ashfield et al., 1998; 
Schäfers et al., 2007; Shved et al., 2008). The present study identified concentration-dependent 
modulation of genes associated with negative cell growth regulation (e.g. ghr-1, igfbp-1, 
myostatin) (Table 4, Fig. 3, 6C and D, Suppl. table B, E), whereof  several genes have been 
reported regulated in EE2 exposed fish elsewhere (Martyniuk et al., 2007; Shved et al., 2008). 
Impaired cell and organism growth has previously been correlated with disruption of steroid 
homeostasis and reproduction in fish, potentially due to energetic constraints introduced by 
simultaneously occurring energy demanding processes such as  reproduction, growth (Davis et 
al., 2008) and detoxification of xenoestrogens (Schäfers et al., 2007). Although not studied in 
detail, this may also be applicable to the primary hepatocytes studied herein as they likely have 
limited energy/lipid storage capacity and lack the ability to compensate large energy losses by 
mobilization of nutrients from other tissues. However, additional explanations such as nuclear 
receptor cross-talk between the ER and GH/IGF-1 systems leading to suppression of ghr, igfbp-
1 genes has been proposed to explain estrogen-induced impairment of growth during sexual 
differentiation in fish (Davis et al., 2008; Nelson and Habibi, 2013; Shved et al., 2008). The 
findings of the present in vitro study indicate that primary fish hepatocytes retain the molecular 
regulatory networks specifically associated with IGF-1 and GH signaling, and may thus provide 
valuable insight into how these processes are affected after exposure to xenoestrogens in fish.  
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4.5 Cancer and other signaling pathways 
Estrogens exert carcinogenic effects in mammals by ER signaling and transduction pathways 
associated with inhibition of apoptosis and increased cell proliferation (Pearce and Jordan, 
2004; Yager and Davidson, 2006). Evidence of estrogen-induced liver carcinogenesis and 
perturbation of cell cycle regulation has been demonstrated in E2-exposed fish and been 
proposed to result from interference with putative genes associated with cell cycle regulation 
such as G1-S and S-G2 phase transition (Lam et al., 2011), both being mechanisms that regulate 
mitosis and cellular growth. The present study identified that several affected pathways and 
GOs were associated with suppression of cell death (caspase activity, death receptor and 
apoptosis signaling) supported by the suppression (direct inhibitor-of-apoptosis protein-
binding protein with low pI (Diablo), tumor necrosis factor ligand superfamily member 6 
(faslg)) and induction (X-linked inhibitor of apoptosis (xiap)) of putative DEGs, which further 
have been  associated with a number of cancer types (Reed, 2003). Interestingly, the present 
study identified enrichment of several additional pathways associated with cancer (i.e. breast 
cancer regulation by stathmin1, molecular mechanism of cancer and estrogen-dependent breast 
cancer) and regulation of DEGs (reticulon 1/3 (rtn1/3), pim-1/3 oncogene (pim1/3) and breast 
cancer metastasis-suppressor 1-like (brms1)), whereof several have been reported modulated 
in fish exposed to estrogens (Colli-Dula et al., 2014; Harding et al., 2013; Levi et al., 2009). 
However, estrogens have also been proposed to induce oxidative DNA damage (Lam et al., 
2011) through production of reactive metabolites that subsequently may cause mutagenic, 
carcinogenic and genotoxic effects (Roy et al., 2007; Russo et al., 2003). Interestingly, putative 
DEGs involved in DNA damage such as breast cancer 1 (brca1) were suppressed. This seems 
to contradict the behavior of brca1 in E2-exposed fish (Lam et al., 2011). The induction of 
brca1 is primarily mediated by estrogens binding to and activating the ER, but recent studies 
have suggested that recruitment of unliganded AhR to the proximal brca1 transcriptional 
binding domain is required to potentiate its expression (Hockings et al., 2006). Lack of AhR 
  
23 
 
regulation (Suppl. table A and D) after exposure to EE2 in this study suggested that AhR may 
not respond in a similar manner as that seen in vivo. However, the decreased transcription of 
the genes encoding the death receptor (faslg) and proteins involved in apoptosis signaling 
(Diablo and xiap) may suggest that EE2 is associated with estrogen-mediated inhibition of 
apoptosis and induced cell proliferation in primary hepatocytes as observed in vivo (Harding et 
al., 2013; Lam et al., 2011; Levi et al., 2009).  
 
4.6 Primary hepatocytes as a screening model for estrogen mimics  
Rainbow trout hepatocytes have been suggested to be a rapid and high-throughput assay for the 
identification of estrogenic and antiestrogenic properties of chemicals (Hultman et al., 2015; 
Navas and Segner, 2000; Smeets et al., 1999; Tollefsen et al., 2008b), and recently 
demonstrated to yield highly reproducible responses to estrogenic biomarkers such as Vtg 
expression both at the gene and protein level (Hultman et al., 2015). The present study 
demonstrated that the rainbow trout hepatocyte bioassay, in combination with the global 
transcriptional analysis, may provide better understanding of the MoAs of EE2. The main 
advantages of applying this approach to rainbow trout hepatocytes are: low amount of 
biological material required for the analysis, rapid and unbiased MoA characterization and low 
biological variation. The primary hepatocytes displayed well-characterized biomarker gene 
responses, which was generally in agreement with that occurring in vivo in fish after exposure 
to E2 and EE2. This applies in particular to the in vivo expression of DEGs associated with 
estrogen receptor signaling (e.g. esr1, vtg1, zrp) , biotransformation (e.g. cyp1a, abc11b), lipid 
and cholesterol metabolism (e.g. dhcr,fabp3, ldlr), growth (e.g.igfbp-1, ghr), and 
cancer/apoptosis (rtn1/3, pim1/3, xiap, diablo), which were conserved and responsive in the 
rainbow trout hepatocyte model. The observed in vitro transcriptional changes increased in 
number of DEGs identified and their responses to EE2, a finding also seen when analyzing 
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functional (GO) enrichment and pathway analysis. Interestingly, the sensitivity of the 
hepatocytes to well-known biomarkers such as vtg, esr1 and cyp1a also seemed to be in 
accordance with that observed in in vivo exposure studies with 0.87-125 ng/L EE2 (Doyle et 
al., 2013; Gunnarsson et al., 2007; Hoffmann et al., 2006; Martyniuk et al., 2007; Skillman et 
al., 2006). The in vitro to in vivo extrapolation performed followed principles demonstrated by 
Skillman et al. (2006) by using measured liver cell concentrations of EE2 in the hepatocyte 
assay (see Hultman et al., 2015). Using a fixed water:liver EE2 accumulation ratio derived from 
a 48h in vivo exposure study to 125 ng/L EE2 (Skillman et al., 2006), the in vitro Lowest 
Observed Effect Concentration (LOEC = 0.3 nM, fig. 3) were estimated to correspond to an 
external water exposure concentration of 6.4-9.6 ng/L in the present study. These external 
exposure concentrations has been demonstrated not only to be in the range of sensitivity 
observed in vivo (Gunnarsson et al., 2007; Martyniuk et al., 2007), but also considered to be 
environmentally relevant (Larsson et al., 1999).  
Although molecular methods such as transcriptomics have greatly improved our ability to 
perform global response assessments, transcriptional regulation will not account for 
posttranscriptional modifications leading to alterations of downstream molecular events such 
protein expression, cellular signaling, and metabolic activity (Schirmer et al., 2010).  However, 
close correlation of Vtg gene and protein expression were observed in the same experimental 
models (Hultman et al., 2015), and suggest that certain transcriptional responses are descriptive 
for the activity occurring at the functional level. As a thorough evaluation of the predictability 
of transcriptional changes to other levels of organization was not conducted in the present study, 
it is recommended that such effort is undertaken in the future characterization of MoAs of EE2 
and other xenoestrogens. The use of primary hepatocytes also has some limitations for larger 
scale implementation in MoA assessment of EDCs as the bioassay is restricted to hepatic 
responses and does not necessarily reflect MoAs relevant for other organs (e.g. oocyte 
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formation) and adverse effects (e.g. feminization) at the whole organism level. However, this 
may also be advantageous as the primary hepatocytes reflect key molecular events in the liver 
and can thus be studied without influences from other organs involved in the hypothalamus-
pituary-gonad axis. Overall, rainbow trout hepatocytes seem to represent a feasible complement 
to in vivo testing as displaying many central hepatic MoA relevant for endocrine disruption, 
and in particular the response to ER agonists.  
 
5 Conclusion 
The present study showed that the primary rainbow trout hepatocyte bioassay can be a suitable 
and responsive in vitro model when using a broad content transcriptomic analysis to 
characterize the effects of the ER-agonist 17α-ethinylestradiol (EE2). The potential toxic 
mechanisms of EE2 in the primary hepatocytes were successfully characterized and found to 
affect gene expression related to biotransformation, lipid metabolism and ER signaling and ER-
mediated cellular responses. The potential of using primary hepatocytes for assessment of 
estrogen mimics was supported by the clear concentration–dependent enrichment of functional 
categories (GO), pathways and DEGs associated with the well-known MoAs of EE2 (e.g. 
induction of estrogen signaling, suppression of biotransformation and growth, disruption of 
lipid homeostasis, and cancer) in vivo. Furthermore, well-characterized estrogen-responsive 
biomarker genes (e.g. esr1, vtg, zrp) were identified to be differentially expressed in accordance 
with several previous in vitro and in vivo estrogen studies. The primary hepatocyte model is 
thus proposed to represent a promising complement to in vivo testing of EDCs, and in particular 
for estrogen mimics that affect central liver functions associated with endocrine regulation and 
reproductive processes in fish.  
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Figures 
 
Figure 1. Differentially (up- and down-) expressed genes (DEGs) in primary rainbow trout 
(Oncorhynchus mykiss) hepatocytes exposed to 0.03, 0.3, 3 and 30 nmol/L 17α-
ethynylestradiol (EE2) for 48h. 
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Figure 2. Toxicity pathways associated with the modulation of differently expressed genes 
(DEGs) in primary rainbow trout (Oncorhynchus mykiss) hepatocytes exposed to 17α-
ethynylestradiol (EE2) for 48h. All chemical concentrations having significant enrichment of 
relevant toxicity pathways are in the figure represented by individual bars.   
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Figure 3. A comparison of gene expression in primary rainbow trout (Oncorhynchus mykiss) 
hepatocytes exposed to 17α-ethynylestradiol (EE2) for 48h. Data (Mean ± SEM) depicts 
quantitative real time polymerase chain reaction, qPCR (open boxplots, n=3-4) and microarray 
(filled boxplots, n=4). *Denotes genes being significantly different (p<0.05) from the solvent 
control. Abbrevations: cyp1a1 – cytochrome P450 1a1; esr1 – estrogen receptor 1; fst - 
follistatin; ghr-1 – growth hormone receptor 1; igfbp-1 – insulin growth factor binding protein 
1; pparα – peroxisome proliferator-activated receptor α; pparγ – peroxisome proliferator-
activated receptor γ; vtg1 – vitellogenin 1. 
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Figure 4. Gene expression of proliferator-activated receptor α (pparα) in primary rainbow trout 
(Oncorhynchus mykiss) hepatocytes exposed to 17α-ethynylestradiol (EE2) for 48h. Data 
(Mean ± SEM) depicts quantitative real time polymerase chain reaction, qPCR (open boxplots, 
n=3). *Denotes the gene being significantly different (p<0.05) from the solvent control.  
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Figure 5. Estrogen receptor (ER) signaling pathway in fish based on differential gene 
expression in primary rainbow trout hepatocytes exposed to 17α-ethynylestradiol (EE2) for 
48h. Abbrevations: HSP90 - heat shocking protein 90; ERE – Estrogen responsive element; 
NCOA4 - nuclear receptor coactivator 4, NR2F1- nuclear receptor subfamily group member 1; 
NR0B2 - nuclear receptor subfamily group member 2 ; TAF1A – TATA box-binding protein-
associated factor RNA polymerase I subunit A; IGFBP-1 – insulin growth factor binding 
protein 1; IGF-1 – insulin growth factor 1; GHR – growth hormone receptor; VTG – 
vitellogenin; ZRP3/4 – zona radiata protein 3/4; PPARα/γ – peroxisome proliferator-activated 
receptor α/γ, FABP-3 – fatty acid binding protein 3. The pathway is modified from Lanzino et 
al., (2005), Petit et al., (1999) and Sanyal et al., (2002). 
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Figure 6. Concentration-dependent modulation of toxicity (canonical) pathways and 
supporting differently expressed genes (DEGs) in primary rainbow trout (Oncorhynchus 
mykiss) hepatocytes exposed to 0.03 (A), 0.3 (B), 3 (C) and 30 (D) nmol/L 17α-ethynylestradiol 
(EE2) for 48 hours.  
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Tables 
 
 
Target gene   Primer sequence 
Amplicon size 
Annealing temperature 
Primer conc.  
(nmol/L) 
Efficiency  
(%) Acc. no      
 
Reference 
Ef1α -forward 5'-AGCGCAATCAGCCTGAGAGGTA-3' 
 
 
NR 62°C 600 
 
 
107.5 NM_001141909.11) 
 
Gabillard et al., 2006 
  -reverse 5'-GCTGGACAAGCTGAAGGCTGAG-3' 
 
 600 
 
  
 
      
 
   
 
  
 
PPARα -forward 5'-CTGGAGCTGGATGACAGTGA-3' 
 
 
195 55°C 500 
 
 
95.0 AY494835 
 
Cruz-Garcia et al., 
2002 
  -reverse 5'-GGCAAGTTTTTGCAGCAGAT-3' 
 
 500 
 
  
 
   
 
  
 
 
 
PPARγ -forward 5'-GACGGCGGGTCAGTACTTTA-3' 
 
 
171 60°C 700 
 
 
94.2 AY356399.1 
 
Cruz-Garcia et al., 
2002 
  -reverse 5'-ATGCTCTTGGCGAACTCTGT-3' 
 
 700 
 
  
 
   
 
  
 
 
 
ERα -forward 5'-CCCTGCTGGTGACAGAGAGAA-3' 
 
 
NR 61°C 270 
 
 
99.9 AJ242741 
 
Nagler et al., 2007 
  -reverse 5'-ATCCTCCACCACCATTGAGACT-3' 
 
 620 
 
  
 
   
 
  
 
 
 
Vtg -forward 5'-GAGCTAAGGTCCGCACAATTG-3' 
 
 
NR 61.4°C 700 
 
 
110 X92804 
 
Celius et al., 2000 
  -reverse 5'-GGGAAACAGGGAAAGCTTCAA-3' 
 
 700 
 
  
 
   
 
  
 
 
 
GHR-1 -forward 5'-CGTCCTCATCCTTCCAGTTTTA-3' 
 
 
NR 62°C 500 
 
 
97.0 NM_001124535.11) 
 
Gabillard et al 2006 
  -reverse 5'-GTTCTGTGAGGTTCTGGAAAAC-3' 
 
 500 
 
  
 
Table 1. Genes, primer sequences, accession numbers and analysis protocol used for the qPCR analysis.  
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IGFBP-1 -forward 5'-AGTTCACCAACTTCTACCTACC-3' 
 
 
NR 62°C 700 
 
 
107.2 NM_001124561.11) 
 
Gabillard et al 2006 
  -reverse 5'-GACGACTCACACTGCTTGGC-3' 
 
 700 
 
  
 
   
 
  
 
 
 
CYP1A -forward 5'-TCCTGCCGTTCACCATCCCACACTGCAC-3' 
 
NR 
57°C 700 
 
 
90.5 U62797.1 
 
Gräns et al., 2010 
  -reverse 5'-AGGATGGCCAAGAAGAGGTAGACCTC-3' 
 
NR  700 
   
  
 
          
      
 
 
 
 
 
 
 
 
 
Footnotes 
1) Acc. No. was not provided by reference. 
 
Abbreviations: nM – nmol/L; ef1α – Elongation factor 1 α; pparα – Peroxisome proliferator-activated receptor α; pparγ - Peroxisome proliferator-activated receptor γ; esr1 – Estrogen receptor 
1/α; vtg – Vitellogenin; ghr-1 – Growth hormone 1; igfbp-1 - Insulin growth factor protein 1; cyp1a – Cytochrome P450 1A    
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 nmol/l GO-ID 
GO 
namesp
ace 
P-value 
(<0.05) 
No. of 
DEGs 
Total 
features 
 on array 
GO Term 
Functional 
category 
0.3    GO:0019216 P 2.69E-02 5 270 Regulation of lipid metabolic process 
Lipid and fatty acid 
metabolism 
    GO:0019395 P 2.69E-02 4 154 Fatty acid oxidation   
    GO:0034440 P 2.69E-02 4 154 Lipid oxidation   
    GO:0046320 P 3.65E-02 3 74 Regulation of fatty acid oxidation   
                  
    GO:0043154 P 4.15E-03 4 46 Negative regulation of caspase activity Programmed cell death 
    GO:0043028 F 3.65E-02 3 74 
 
Caspase regulator activity:Regulation of caspase 
activity 
  
    GO:0043027 F 1.28E-02 3 35 
Caspase inhibitor activity: Regulation of caspase 
activity 
  
                  
                  
3    GO:0060397 P 2.57E-02 3 13 
JAK-STAT cascade involved in growth hormone 
signaling pathway 
Cell Growth and 
development 
                  
    GO:0046543 P 4.19E-03 3 5 
 
Development of secondary female sexual 
characteristics 
Reproduction 
    GO:0032504 P 1.72E-02 21 838 Multicellular organism reproduction   
    GO:0048609 P 1.72E-02 21 838 Reproductive process in a multicellular organism   
    GO:0000003 P 2.24E-02 28 1344 Reproduction   
    GO:0022414 P 2.76E-02 27 1330 Reproductive process   
    GO:0045136 P 3.22E-02 3 15 Development of secondary sexual characteristics   
    GO:0046544 P 2.57E-02 2 3 
 
Development of secondary male sexual 
characteristics 
  
                  
Table 2. Common Gene Ontology (GO) processes over-represented in primary rainbow trout (Oncorhynchus mykiss) hepatocytes after 48h 
exposure to 17α-ethinylestradiol (EE2). The exposure to 0.03 nmol/l did not yield any significant enrichment of GOs. 
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    GO:0019395 P 2.18E-02 8 154 Fatty acid oxidation 
Lipid and fatty acid 
metabolism 
    GO:0034440 P 2.18E-02 8 154 Lipid oxidation   
    GO:0010876 P 2.18E-02 14 446 Lipid localization   
    GO:0006635 P 2.57E-02 6 89 Fatty acid beta-oxidation   
    GO:0006631 P 2.76E-02 15 539 Fatty acid metabolic process   
    GO:0015645 F 2.57E-02 5 55 Fatty acid ligase activity   
                  
    GO:0035257 F 3.67E-02 8 182 
 
Nuclear hormone receptor binding: Hormon 
receptor binding 
Regulation of endocrine 
system 
    GO:0005102 F 3.94E-02 31 1661 Receptor binding: Hormon receptor binding   
    GO:0035258 F 6.38E-03 7 83 
 
Steroid hormone receptor binding: Hormon receptor 
binding 
  
    GO:0050681 F 2.57E-02 5 59 
Androgen receptor binding: Hormon receptor 
binding 
  
                  
                  
30    GO:0040008 P 3.97E-02 18 753 Regulation of growth 
Cell Growth and 
development 
    GO:0040008 P 3.79E-05 40 753 Regulation of growth   
    GO:0040007 P 6.67E-05 56 1294 Growth   
    GO:0016049 P 2.25E-03 29 576 Cell growth   
    GO:0001558 P 2.37E-03 24 435 Regulation of cell growth   
    GO:0035264 P 7.27E-03 13 171 Multicellular organism growth   
    GO:0045454 P 1.51E-02 12 164 Cell redox homeostasis   
    GO:0030308 P 2.79E-02 13 208 Negative regulation of cell growth   
    GO:0045926 P 3.11E-02 14 239 Negative regulation of growth   
    GO:0007275 P 4.21E-02 191 7536 Multicellular organismal development   
    GO:0060397 P 1.16E-02 4 13 
 
JAK-STAT cascade involved in growth hormone 
signaling pathway 
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    GO:0000003 P 2.25E-03 52 1344 Reproduction Reproduction 
    GO:0032504 P 2.37E-03 37 838 Multicellular organism reproduction   
    GO:0048609 P 2.37E-03 37 838 Reproductive process in a multicellular organism   
    GO:0022414 P 4.91E-03 50 1330 Reproductive process   
    GO:0046543 P 9.60E-03 3 5 
 
Development of secondary female sexual 
characteristics 
  
    GO:0019953 P 2.53E-02 30 737 Sexual reproduction   
                  
    GO:0032355 P 3.63E-02 8 91 Response to estradiol stimulus 
Regulation of endocrine 
system 
    GO:0042562 F 4.19E-02 7 73 Hormone binding   
               
               
                  
Abbreviations 
P - biological process; F - molecular function; DEGs – differently expressed genes 
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EE2 Conc. 
(nmol/L) Top network function Score DEGs 
0.03 Cell Signaling, Molecular Transport, Nucleic Acid Metabolism 80 34 
    
0.3 Cellular Function and Maintenance, Small Molecule Biochemistry, Cellular Development 109 46 
    
3 Hematological Disease, Hereditary Disorder, Carbohydrate Metabolism 172 98 
 Cellular Assembly and Organization, Cellular Function and Maintenance, Lipid Metabolism 100 65 
 Cellular Development, Cellular Growth and Proliferation, Cell Cycle 91 63 
 Cell Death and Survival, Post-Translational Modification, Cardiac Necrosis/Cell Death 11 14 
    
30 Post-Translational Modification, Lipid Metabolism, Small Molecule Biochemistry 121 89 
 Embryonic Development, Organ Development, Organismal Development 104 81 
 Cellular Assembly and Organization, Cellular Function and Maintenance, Cellular Movement 99 80 
 Post-Translational Modification, Cell Signaling, Hereditary Disorder 85 70 
 Amino Acid Metabolism, Small Molecule Biochemistry, Connective Tissue Disorders 82 69 
 Cell Cycle, Tissue Morphology, Cancer 63 58 
 Cell Morphology, Cellular Function and Maintenance, Cell Cycle 63 59 
Score – Numerical value used to rank networks according to their degree of relevance to the Network Eligible molecules in your dataset according to Ingenuity pathway analysis (definition by IPA).  
DEGs – Differently expressed genes 
 
 
 
Table 3. Top gene networks (score>10, supporting genes >10) and supporting differently expressed genes (DEGs) 
in primary rainbow trout (Oncorhynchus mykiss) hepatocytes after 48h exposure to 17α-ethinylestradiol (EE2). 
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EE2 conc. 
(nmol/L) Apical toxicological category  
Ingenuity Canonical 
pathway 
P-valuea Ratio Supporting DEGs 
 
0.03 Intracellular and Second-  
Glucocorticoid Receptor 
Signaling 
1.35E-2 1.00E-2 JAK1↓,POU2F1↓,NPPA↓ 
 
Messenger Signaling Insulin Receptor Signaling 2.69E
-2 1.34E-2 JAK1↓, PPP1CB↑ 
           
0.3 Apoptosis Apoptosis Signaling 2.09E-2 2.00E-2 ROCK1↑,XIAP↑ 
           
3 
 
Apoptosis Death Receptor Signaling 
3.16E-2 
 
4.41E-02 
DIABLO↓,XIAP↑,FASLG↓ 
   Apoptosis Signaling 2.04E-2 4.00E-02 ROCK1↑,DIABLO↓,XIAP↑,FASLG↓ 
           
 
Disease-Specific Pathways 
Estrogen-Dependent Breast 
Cancer Signaling 
3.89E-2 4.11E-2 STAT5A↑, STAT5B↑, Creb5↑ 
           
 Immune Response IL-6 Signaling 4.90E-2 3.23E-2 GRB2↑, CRP↑, STAT3↓, CEBPB↓ 
           
 
Intracellular and Second-  
Calcium Signaling 
2.04E-2 
 
2.76E-2 
 
MYL2↑, RYR3↑, HDAC10↓, ASPH↑, CABIN1↑, Creb5↑ 
 
Messenger Signaling 
Glucocorticoid Receptor 
Signaling 
1.26E-2 
 
2.68E-2 
 
STAT5A↑, POU2F1↓, GRB2↑, STAT3↓, CEBPB↓, NPPA↓, STAT5B↑, 
POLR2I↓ 
 
  
Phospholipase C Signaling 
6.76E-3 
3.02E-2 
 
MYL2↑, GRB2↑, GNB2L1↑, HDAC10↓, GNG3↓, PLA2G12B↑, RHOF↓, 
Creb5↑ 
           
 Nuclear Receptor Signaling PXR/RXR Activation 4.47E-2 3.02E-2 CPT1A↑,ABCB11↑,IGFBP1↓ 
 
  TR/RXR Activation 1.82E
-2 3.67E-2 TSHB↑, NCOA4↑, PFKP↑, TBL1XR1↓ 
   Androgen Signaling 4.37E-2 2.76E-2 GNB2L1↑, NCOA4↑, GNG3↓, POLR2I↓ 
Table 4. A selection of relevant canonical pathways and supporting differentially expressed genes (DEGs) in primary rainbow trout 
(Oncorhynchus mykiss) hepatocytes after 48h exposure to 17α-ethinylestradiol (EE2). Arrows indicates ↑ up- and ↓ down-regulation of DEGs. 
Full description of gene symbols is found in supplementary table A. 
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LPS/IL-1 Mediated Inhibition of 
RXR Function 
4.79E-2 2.45E-2 CPT1A↑, ACSL5↑, ABCB11↑, SLC35A2↑, FABP3↑, ACOX3↑ 
           
 
Metabolic Pathways Thyroid Hormone Biosynthesis 
3.47E-2 
 
1.43E-2 
IYD↓ 
 
          
 
          
 
30 Disease-Specific Pathways 
Molecular Mechanisms of 
Cancer 2.75E-2 
 
3.87E-2 
MAP2K4↓, RAPGEF1↑, JAK1↓, GRB2↑, XIAP↑, CDC25B↑, PTK2↓, 
GNAI2↑, 
 
  
      
LAMTOR3↓, PRKCD↓, ARHGEF11↑, BMP6↑, RHOF↓, DIABLO↓, 
PTCH2↑ 
 
          
 
Cell Growth and development 
Corticotropin Releasing 
Hormone Signaling 2.4E-2 
 
4.83E-2 
GNAI2↑, PRKCD↓, NPR1↓, JUND↑, OPN1SW↑, PTCH2↑, Creb5↑ 
 
          
 
Neurotransmitters and Other  GNRH Signaling 
5.62E-3 
 
5.88E-2 
MAP2K4↓, PTK2↓, GNAI2↑, GRB2↑, PRKCD↓, MAP3K8↑, OPN1SW↑, 
MAP3K2↑, Creb5↑ 
 Nervous System Signaling       
           
 Nuclear receptor signaling PPAR Signaling 3.16E-2 5.61E-2 IL33↑,NR2F1↑,STAT5A↑,NR0B2↑,GRB2↑,STAT5B↑ 
           
 
Intracellular and Second-  Insulin Receptor Signaling     EIF2B1↑, GRB2↑, JAK1↓, PPP1CB↑, PPP1R7↓, PPP1R3C↑, RAPGEF1↑ 
 
Messenger Signaling         
 
          
 
Metabolic Pathway 
CDP-diacylglycerol 
Biosynthesis I 
5.75E-3 1.11E-1 
GPAM↑, CDS1↓, CDS2↓ 
 
          
 Commonly regulated between 3 
and 30nMc   
    
 
Immune Response CXCR4 Signaling 5.50E-3 5.75E-2 
MAP2K4↓, PTK2↓, ROCK1↑, GNAI2↑, MYL2↑, PRKCD↓, ARHGEF11↑, 
GNG3↓, RHOF↓, OPN1SW↑ 
 
  CCR3 Signaling in Eosinophils 2.63E-2 5.22E-2 
ROCK1↑, GNAI2↑, PRKCD↓, PPP1CB↑, GNG3↓, PLA2G12B↑, 
OPN1SW↑ 
           
 
Intracellular and Second-  
Tec Kinase Signaling 
6.03E-4 
 
6.52E-2 
MAP2K4↓, PTK2↓, GNAI2↑, STAT5A↑, JAK1↓, PRKCD↓, STAT3↓, 
GNG3↓, STAT1↑, STAT5B↑, RHOF↓, ITK↓ 
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a P-value is defined to p < 0.05 
b Ratio is calculated as the number of regulated molecules in a given pathway that meet cutoff criteria, divided by total number of molecules that make up that pathway. 
c Represents 30nM EE2 
 
 
 
 
Messenger Signaling 
Protein Kinase A Signaling 
1.74E-2 
 
4.16E-2 
PTPRG↓, MYL2↑, PPP1R3C↑, PPP1CB↑, GNG3↓, PTPN5↑, Creb5↑, 
CDC25B↑, PTK2↓, ROCK1↑, 
 
        GNAI2↑, ADD3↑, FLNC↑, PPP1R7↓, PRKCD↓, PTCH2↑, OPN1SW↑ 
 
          
 
Neurotransmitters and Other  Neurotrophin/TRK Signaling 
2.82E-2 
 
6.58E-2 
MAP2K4↓, GRB2↑, NTRK1↑, MAP2K5↑, Creb5↑ 
 Nervous System Signaling       
           
 Cell Growth and development Oncostatin M Signaling 1.82E-4 1.71E-1 STAT5A↑, JAK1↓, GRB2↑, STAT3↓,STAT1↑, STAT5B↑ 
 
  Growth Hormone Signaling 7.76E-3 7.69E
-2 STAT5A↑, GHR↓, PRKCD↓, STAT3↓, STAT1↑, STAT5B↑ 
   IGF-1 Signaling 3.63E-2 5.61E
-2 PTK2↓, JAK1↓, GRB2↑, STAT3↓, IGFBP1↓, CYR61↑ 
           
 
Disease-Specific Pathways 
Breast Cancer Regulation by 
Stathmin1 
3.98E-4 6.54E-2 
GRB2↑, PPP1R3C↑, TUBB2A↑, PPP1CB↑, GNG3↓, ROCK1↑, GNAI2↑, 
PPP2CB↑, PPP1R7↓, PRKCD↓, 
 
        PPM1L↑, ARHGEF11↑, TUBA3E↑, OPN1SW↑ 
 
       
